Table 2.
Variable | Univariate analysis
|
Multivariate analysis
|
||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age | 1.045 | 1.03–1.06 | <0.001 | 1.049 | 1.032–1.065 | <0.001 |
Sex | ||||||
Male | Reference | |||||
Female | 0.961 | 0.702–1.317 | 0.806 | |||
Race | ||||||
White | Reference | Reference | ||||
Black | 1.22 | 0.811–1.836 | 0.34 | 1.268 | 0.842–1.91 | 0.256 |
Other | 1.802 | 1.015–3.202 | 0.044 | 1.992 | 1.103–3.595 | 0.022 |
LNs examined | 0.984 | 0.954–1.015 | 0.303 | |||
SEER stage | ||||||
Localized | Reference | Reference | ||||
Regional | 1.701 | 1.115–2.593 | 0.014 | 1.467 | 0.939–2.29 | 0.092 |
Distant | 3.839 | 2.578–5.717 | <0.001 | 2.893 | 1.85–4.514 | <0.001 |
Tumor laterality | ||||||
Unilateral | Reference | Reference | ||||
Bilateral | 1.988 | 1.127–3.51 | 0.018 | 2.014 | 1.111–3.653 | 0.021 |
Year of diagnosis | ||||||
1988 | Reference | |||||
1989–1997 | 2.836 | 0.387–20.778 | 0.305 | |||
1998–2000 | 3.798 | 0.503–28.656 | 0.196 | |||
2000–2014 | 3.156 | 0.434–22.957 | 0.256 | |||
LND stratification | ||||||
Low LND | Reference | Reference | ||||
High LND | 2.804 | 1.998–3.934 | <0.001 | 2.102 | 1.44–3.07 | <0.001 |
Abbreviations: HR, hazard ratio; LNs, lymph nodes; LND, lymph node density; SEER, Surveillance, Epidemiology, and End Result.